SETD1A function in leukemia is mediated through interaction with mitotic regulators BuGZ/BUB3

Area of Science:

• Molecular Biology
• Cancer Biology
• Epigenetics

Background:

• The H3K4 methyltransferase SETD1A is essential for leukemia cell survival.
• SETD1A's noncatalytic FLOS domain mediates interactions with cyclin K and regulates DNA damage response genes.

Purpose of the Study:

• To identify functional nuclear localization signals and interaction partners of the SETD1A FLOS domain.
• To investigate the role of SETD1A-BuGZ/BUB3 interactions in leukemia.

Main Methods:

• Protein interaction screening using the SETD1A FLOS domain.
• Functional assays involving inhibition of SETD1A interaction motifs.
• Cell-cycle-specific SETD1A restoration assays.

Main Results:

• The SETD1A FLOS domain binds mitosis-associated proteins BuGZ/BUB3.
• Inhibition of cyclin K and BuGZ/BUB3 binding motifs shows synergistic antileukemic effects.
• BuGZ/BUB3 localize to specific regulatory regions, and their interaction with SETD1A is crucial for proliferation.

Conclusions:

• SETD1A interacts with BuGZ/BUB3, contributing to leukemia cell survival and proliferation.
• Targeting SETD1A interactions with cyclin K and BuGZ/BUB3 offers a potential synergistic therapeutic strategy for leukemia.
• SETD1A expression during the G1/S phase is critical for DNA damage response and cell cycle progression in leukemia.